Trade Moderna, Inc. - MRNA stock price

What is Moderna Inc?

Moderna Therapeutics is a biotechnology company founded by Robert S Langer, Derrick Rossi, Kenneth R Chien, Timothy A Springer and Noubar Afeyan in 2010 with its headquarters in Cambridge, Massachusetts. Moderna Inc core business activities are drug discovery, development of new drugs and vaccines, based on messenger ribonucleic acid with the application of innovative technology. The therapeutic areas of particular focus for Moderna operations are infectious diseases, immuno-oncology, rare diseases, cardiovascular and autoimmune diseases. The founding investor of Moderna Inc was Flagship Pioneering, a venture capital firm interested in providing funding for companies in sectors such as pharmaceutical, electronics and medical devices.

Moderna, Inc became a publicly-traded company on December 7, 2018 when it raised more than $600m (£459m) and became the largest Initial public offering associated with biotechnology. Moderna is listed on NASDAQ under the MRNA symbol and its shares were sold at $23 (£17.6) which was within the anticipated price range of $22 (£16.8) to $24 (£18.3), making the IPO a success because it raised more than the planned $600m.

Past performance of Moderna stock price

Even though the IPO is considered to be a success, the Moderna stock price has seen some major fluctuations since the company went public. The lowest price at which the company shares were traded was below $13 (£9.95) at the end of July 2019. However, it hit a record high of nearly $95 (£72.74) almost a year later.

Prior to the outbreak of the Covid-19 pandemic the Moderna stock price displayed a range-bound fluctuation in a narrow range. However, with the global spread of the coronavirus, it started to move in an upward trend to the level of £72.74. Another key feature of the Moderna stock price is its tendency to experience gap ups or gap downs which makes this stock also attractive for gap traders.

How to invest in Moderna stock

If you want to invest in Moderna stock you can purchase the shares directly if you expect the value to appreciate over a longer period. Another way is to use innovative financial instruments  – tokenised assets on Currency.com. They reflect the movement in the price of the underlying assets, which offers the possibility of making profits without owning the specific stock.

Aside from the swift execution of transactions at lower fees, trading tokenised shares brings additional advantages. The leverage of up to 1:100 provided by Currency.com creates the possibility of earning higher profits with the same amount of available capital. For example, a position with tokenised Moderna shares would require only 5 per cent of trader's capital, but the potential profits will be generated on the overall position size.

Also, Currency.com pays attention to the need of cryptocurrency owners who often have to convert their crypto holdings into fiat before they start trading. Tokenised Moderna shares allow them to speculate on the price movements directly with Bitcoin or Ether.

Tokenised Moderna stock trading guide

Trading tokenised Moderna stock is no more difficult than regular shares. To begin trading tokenised asset, you will need to follow some simple steps.

• Step 1: register for an account with Currency.com.
• Step 2: deposit funds (with crypto or fiat) in the account.
• Step 3: determine the position size desired, accounting for leverage offered by Currency.com.
• Step 4: determine your trading position (long or short) based on expected share price movement and purchase tokenised MRNA shares derivatives.
• Step 5: Currency.com matches the long orders from its clients with the sell orders and then hedges the unmatched orders through Capital.com, LMAX Digital or exchanges such as Binance, Bitstamp, Kraken, NASDAQ, NYSE and Gain Capital.
• Step 6: close your position when applicable. You can set a take profit or stop loss indicator to ensure you are not required to constantly monitor the price. Funds will deposit back to your account after closing and you can withdraw or take a new position.

Why trade tokenised Moderna stocks with Currency.com

Moderna stock trading at Currency.com tokenised assets exchange has a number of advantages. Tokenised assets are underpinned by robust and immutable blockchain technology. Opening a trade will give you a token that tracks and moves according to the underlying instrument’s price.

• One-stop crypto trading platform

Trade tokenised Moderna shares with Bitcoin or Ethereum. Benefit from the stock’s price movements without turning your crypto assets into fiat.

• Tight spreads

Trade tokenised Moderna stocks with a tight market spread, benefit from maker rebates and competitive taker fees.

• Leverage

Experienced traders can trade the world’s top markets, such as Moderna Inc, with up to 1:100 leverage.

• Effective risk management

Manage your risks and secure your profits with stop loss and take profit orders. Save your assets with negative balance protection.

• Instant order execution

We have a scalable and low latency order management system, which can execute 50 million trades per second. 

• Safe regulation

Currency.com operates under new Belarusian regulation with best-in-class AML and KYC laws. Regulatory details and fees are upfront.